Aegis InterACT RxTM allows for detection of recently ingested substances that are capable of interacting negatively with pain management and behavioral health medications. It is an objective tool designed to reduce the risk of adverse drug events associated with DDIs that may be missed by traditional methods.
Use objective information to encourage open communication about the impact of DDIs on patient care
Equip yourself with actionable information to allow for sensible transitions to more appropriate therapy and discontinuation of offending agents
Definitively detect barriers to effective care to better identify DDIs and make informed medication management decisions